Back Pain in Adolescents and Young Adults: A Retrospective Review of Psychosocial Factors and Treatment Strategies
Heather M. Richard, Mutaleeb A. Shobode, Asahi Murata, Gerrit Franko, Adam Mansour, Melissa Owusu-Ansah, Chen Li, Bahja Muse, Josiah J. Wolf, Allen Kadado, Kirsten Tulchin-FrancisBackground
Nonspecific back pain is increasingly encountered in pediatric orthopaedic clinics. These visits are often complex and time-intensive, yet surgical intervention is rarely indicated. This study describes the characteristics of patients presenting with back pain at a single pediatric institution and examines associated biopsychosocial factors.
Methods
An IRB-approved retrospective review was conducted of patients aged 7 to 22 years presenting with back pain to pediatric orthopaedic and sports medicine clinics in 2021. Demographic, clinical, imaging, and behavioral health data were extracted from the electronic medical record. Patients were categorized based on the presence or absence of structural spine diagnoses. Comparative analyses were performed between groups. Multivariable logistic regression was used to identify independent predictors of persistent symptoms at follow-up.
Results
A total of 869 patients were included [mean age: 15.0±2.6 y; 537 (61.8%) female]. Chronic back pain was present in 631 patients (72.6%), and structural diagnoses were identified in 327 patients (37.6%), most commonly spondylolysis (14.6%) and scoliosis (14.3%). Behavioral health diagnoses were documented in 328 patients (37.7%). Pain severity did not differ significantly between patients with and without structural diagnoses (5.6±2.3 vs. 5.5±2.2;
Conclusions
In pediatric back pain, structural pathology was not independently associated with symptom persistence. Behavioral health factors demonstrated stronger associations with symptom burden and clinical outcomes, supporting a biopsychosocial model of care. Routine integration of behavioral health assessment may improve management and reduce persistent symptoms in this population.
Levels of Evidence:
Level III—retrospective cohort study.